Detalhe da pesquisa
1.
Platelet activating factor receptor acts to limit colitis-induced liver inflammation.
FASEB J
; 34(6): 7718-7732, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293760
2.
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Gut
; 68(3): 465-474, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29382774
3.
WNT as a Driver and Dependency in Cancer.
Cancer Discov
; 11(10): 2413-2429, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518209
4.
An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants.
Cancer Discov
; 10(11): 1654-1671, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32792368
5.
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Lancet Gastroenterol Hepatol
; 3(9): 635-643, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042065
6.
MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
Cancer Discov
; 8(8): 988-1005, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880585
7.
FOXO3 Loss Drives Inflammation-Associated CRC: The Consequences of Being (Knock)Out-FOX'd.
Cell Mol Gastroenterol Hepatol
; 7(2): 295-296, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529280
8.
MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer.
Oncotarget
; 9(69): 33056-33058, 2018 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237848